NCT06710132

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: ACTIVE_NOT_RECRUITING

Phase: PHASE1, PHASE2

Sponsor: EMD Serono Research & Development Institute, Inc.

Condition: Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

Signal summary

Status signal: Low Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: large_enrollment_target_signal | rare_population_signal

Stopped reason

No stop reason available in the current public record.